Smart Pills Market Overview, Growth, Trends, Analysis, Research Report (2021-2031)

Smart Pills Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Capsule Endoscopy, Drug Delivery, and Patient Monitoring), Disease Indication (Gastrointestinal Diseases, Neurological Disorders, Cancer, Inherited Disorders, and Other Disease Indications), End User (Hospitals and Clinics, Research Institutes, and Home Healthcare), and Geography

  • Report Code : TIPHE100001238
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Smart Pills Market Growth Drivers and Opportunities by 2031

Buy Now

The smart pills market size is projected to reach US$ 13.22 billion by 2031 from US$ 5.01 billion in 2023. The market is expected to register a CAGR of 12.9% during 2023–2031. Remote patient monitoring through smart pills is likely to remain a key trend in the market.

Smart Pills Market Analysis

Worldwide IBS and colon cancer incidences are growing dramatically; this is expected to serve critical growth opportunities for the smart pills market. For instance, according to the published article by the National Center for Biotechnology Information, IBS prevalence among people in Spain is  approximately 10%. Furthermore, globally, IBS affects around 11% of the population. Such growing IBS and cancer cases will fuel the smart pills market.

Smart Pills Market Overview

The prevalence of chronic diseases such as cancer, neurological disease, gastrointestinal diseases, and others is leading to various growth opportunities for the smart pill manufacturers to enter the market. The rising geriatric population is also likely to increase the demand for the smart pills market. Geriatric populations are more prone to neurological conditions such as dementia and Alzheimer’s disease, which increases the use of smart pills and shows a positive impact on the market. According to arc.aarpinternational.org, Germany is one of only five “super-aged” societies worldwide. By 2034, 24 million people in Germany will be 65 years or older, which is 31% of the population.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Smart Pills Market: Strategic Insights

Smart Pills Market

  • CAGR (2023 - 2031)
    12.9%
  • Market Size 2023
    US$ 5.01 Billion
  • Market Size 2031
    US$ 13.22 Billion

Market Dynamics

GROWTH DRIVERS
  • Rising Incidence of IBD and Other Chronic Diseases
FUTURE TRENDS
  • Increase in Strategic Collaborations & Partnerships On Smart Pills to Favor Market
OPPORTUNITIES
  • Increasing Research For Efficient Approach To Assessing GI Motility

Key Players

  • CapsoVision, Inc.
  • Given Imaging, Inc.
  • Check-Cap
  • PENTAX Medical
  • Olympus
  • BodyCap
  • Otsuka America Pharmaceutical, Inc.
  • IntroMedic
  • Jinshan Science & Technology (Group) Co., Ltd.
  • RF Co., Ltd.

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Application
  • Capsule Endoscopy
  • Drug Delivery
  • Patient Monitoring
Disease Indication
  • Gastrointestinal Diseases
  • Neurological Disorders
  • Cancer
  • Inherited Disorders
  • Other Disease Indications
End User
  • Hospitals
  • Clinics
  • Research Institutes
  • Home Healthcare
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Smart Pills Market Drivers and Opportunities

Increase in Strategic Collaborations & Partnerships On Smart Pills to Favor Market

In April 2023, Caltech researchers partnered with researchers at the Massachusetts Institute of Technology and developed the smart-pill technology to diagnose gut disorders. The research was supported in part by the U.S.-based National Science Foundation. Furthermore, in April 2022, the AARDEX group added EtectRx’s smart pills to their MEMS adherence hardware ecosystem. This new collaboration combines etectRx’s smart pill, AARDEX Group’s MEMS Adherence Software (MEMS AS) the ID-Cap System, and to trace medication-taking behaviours. Furthermore, they provide an accurate method to measure and control adherence to solid dosage medicines.

Increasing Research For Efficient Approach To Assessing GI Motility

Existing smart pills do not offer a high spatial resolution, large field-of-view (FOV), and fully wireless operation. Therefore, researchers from NYU Abu Dhabi (NYUAD) developed a new, non-invasive system to assist diagnosis and treatment of gastrointestinal motility disorders. They have generated 3D magnetic field gradients using high-frequency electromagnetic coils that encode each spatial point with a distinct magnetic field magnitude that can track the development of smart pill through the Gastrointestinal (GI) tract. Using bluetooth the field magnitude can determine precise location and transport to a smartphone. Even for electromagnets apply GI motility, and magnetic field can be incorporated into backpacks and jackets.

Smart Pills Market Report Segmentation Analysis

Key segments that contributed to the derivation of the smart pills market analysis are application, indication, and end user.

  • Based on application, the smart pills market is bifurcated into capsule endoscopy, drug delivery and patient monitoring. Capsule endoscopy is further sub-segmented into colon capsule endoscopy, small bowel video capsule endoscopy, storable capsule endoscope, controllable capsule endoscopy, and others. The capsule endoscopy segment held a larger market share in 2023.
  • Based on indication, the smart pills market is divided gastrointestinal diseases, neurological disorders, cancer, inherited disorders and other disease indications. The gastrointestinal diseases segment held a larger market share in 2023.
  • Based on end user, the smart pills market is divided into research institutes, hospitals and clinics, and home healthcare. The hospitals and clinics segment held a larger market share in 2023.

Smart Pills Market Share Analysis by Geography

The geographic scope of the smart pills market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America has dominated the market and Asia Pacific is anticipated to grow with the highest CAGR in the coming years. The growing prevalence of gastrointestinal diseases will likely demand smart pills in Australia. IBS develops in 1 in 5 Australians at some point in their lifetime. Also, every year, more than 800 cases of Ulcerative colitis (UC) are diagnosed in Australia. In addition, according to Australian Government, bowel cancer is the second most significant cancer deaths in Australia and affect 1 in 14 people. People of different ages, between 50 and 74 are at a higher risk and it mainly affects both men and women. Thus, the growing prevalence of gastrointestinal diseases will likely increase demand for smart pills in this region.

Smart Pills Market Report Scope

Report Attribute Details
Market size in 2023 US$ 5.01 Billion
Market Size by 2031 US$ 13.22 Billion
Global CAGR (2023 - 2031) 12.9%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Application
  • Capsule Endoscopy
  • Drug Delivery
  • Patient Monitoring
By Disease Indication
  • Gastrointestinal Diseases
  • Neurological Disorders
  • Cancer
  • Inherited Disorders
  • Other Disease Indications
By End User
  • Hospitals
  • Clinics
  • Research Institutes
  • Home Healthcare
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • CapsoVision, Inc.
  • Given Imaging, Inc.
  • Check-Cap
  • PENTAX Medical
  • Olympus
  • BodyCap
  • Otsuka America Pharmaceutical, Inc.
  • IntroMedic
  • Jinshan Science & Technology (Group) Co., Ltd.
  • RF Co., Ltd.
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

    Smart Pills Market News and Recent Developments

    The smart pills market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the smart pills market are listed below:

    • HealthBeacon plc extended its platform to manage complex and critical pill regimens by launching its new HB Smart Pills Management System ("HB Smart Pills"). (Source: HealthBeacon plc, Press Release, September 2022)
    • PillSafe new disruptive technology and launched smart pill bottle for prescription drugs designed to ensure safety and compliance with medication in the fight against addictive drugs. (Source: PillSafe, Press Release, January 2024)

    smart pills Market Report Coverage and Deliverables

    The “smart pills Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Smart pills market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Smart pills market trends, as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Smart pills market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments3
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the smart pills market
    • Detailed company profiles
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    Application, Disease Indication, and End User

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

    Frequently Asked Questions


    Which region dominated the smart pills market in 2023?

    North America has dominated the smart pills market.

    What are the driving factors impacting the smart pills market?

    Factors such as rising demand for minimally invasive surgical procedures and increase in strategic collaborations and partnerships will boost the market.

    What are the future trends of the smart pills market?

    Remote patient monitoring through smart pills is likely to remain a key trend in the market.

    What would be the estimated value of the smart pills market by 2031?

    The smart pills market size is projected to reach US$ 13.22 billion by 2031.

    What is the expected CAGR of the smart pills market?

    The market is expected to register a CAGR of 12.9% during 2023–2031.

    Trends and growth analysis reports related to Medical Device : READ MORE..